Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.27 and traded as high as $0.28. Yield10 Bioscience shares last traded at $0.27, with a volume of 276,391 shares traded.
Wall Street Analyst Weigh In
Separately, Lake Street Capital lowered Yield10 Bioscience from a “buy” rating to a “hold” rating in a report on Thursday, February 8th.
Read Our Latest Stock Analysis on YTEN
Yield10 Bioscience Stock Down 2.1 %
Hedge Funds Weigh In On Yield10 Bioscience
A hedge fund recently bought a new stake in Yield10 Bioscience stock. Millennium Management LLC bought a new stake in shares of Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 58,768 shares of the specialty chemicals company’s stock, valued at approximately $132,000. Millennium Management LLC owned 1.20% of Yield10 Bioscience as of its most recent SEC filing. 4.91% of the stock is currently owned by institutional investors and hedge funds.
About Yield10 Bioscience
Yield10 Bioscience, Inc operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions.
Further Reading
- Five stocks we like better than Yield10 Bioscience
- Trading Halts Explained
- Comprehensive PepsiCo Stock Analysis
- How to Evaluate a Stock Before Buying
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.